Research programme: small molecule anticancer therapeutics - TelikAlternative Names: 8967; EAAF; TLK 60357; TLK 60596
Latest Information Update: 16 Mar 2012
At a glance
- Originator Telik
- Class Small molecules
- Mechanism of Action Microtubule protein modulators; Signal transducing adaptor protein inhibitors; Vascular endothelial growth factor receptor-1 antagonists; Vascular endothelial growth factor receptor-2 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Suspended Cancer